The role of novel biomarker HE4 in endometrial cancer: a case control prospective study. (Q46748240)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179397%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

title

The role of novel biomarker HE4 in endometrial cancer: a case control prospective study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179397%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179397%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Francesco Plotti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179397%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Roberto Montera

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179397%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Stella Capriglione

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179397%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Patrizio Damiani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179397%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Roberto Ricciardi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179397%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Alessia Aloisi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179397%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Daniela Luvero

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179397%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Ester Valentina Cafà

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179397%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Nella Dugo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179397%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Michela Angelucci

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179397%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Pierluigi Benedetti-Panici

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179397%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

20 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179397%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179397%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179397%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179397%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

page(s)

571-576

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23179397%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s13277-012-0583-0

18 February 2020

exact match

0 references

cites work

Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0583-0

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0583-0

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0583-0

How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0583-0

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0583-0

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0583-0

Model-based insights into multi-host transmission and control of schistosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0583-0

Does HE4 have a role as biomarker in the recurrence of ovarian cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0583-0

Serum and tissue measurements of CA72-4 in patients with endometrial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0583-0

Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0583-0

Radiation-induced CA 125 production by mesothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0583-0

Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0583-0

Immunosuppressive acidic protein in patients with gynecologic cancer

21 January 2018

1 reference

12 December 2020

Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer

1 reference

12 December 2020

CA 15-3 as a tumor marker in gynecological malignancies

1 reference

12 December 2020

TATI (tumor associated trypsin inhibitor) and cancer antigen 125 (CA 125) in patients with early-stage endometrial cancer

1 reference

12 December 2020

The value of serum CA 125 and association CA 125/CA 19-9 in endometrial carcinoma

1 reference

12 December 2020

Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma

1 reference

12 December 2020

Tissue and serum CA125 expression in endometrial cancer

1 reference

12 December 2020

Is OVX1 a suitable marker for endometrial cancer?

1 reference

12 December 2020

Macrophage colony-stimulating factor 1, a clinically useful tumor marker in endometrial adenocarcinoma: comparison with CA 125 and the aminoterminal propeptide of type III procollagen

1 reference

12 December 2020

A comparison of pretreatment serum levels of four tumor markers in patients with endometrial and cervical carcinoma

1 reference

12 December 2020

Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinoma

1 reference

12 December 2020

HE4 expression can be associated with lymph node metastases and disease-free survival in breast cancer.

1 reference

12 December 2020

Utility of tumor marker HE4 to predict depth of myometrial invasion in endometrioid adenocarcinoma of the uterus

1 reference

12 December 2020

Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer?

1 reference

12 December 2020